About this Event:
3DHEALS community events focus on creating educational content and networking events with highly selected speakers and audiences all over the world. This will be the first such event in Singapore. The event is limited to 50 attendees. 
 
Location: 
National University Singapore
Seminar room, Innovation 4.0 Building
3 Research Link 
Singapore,117603

[pdf-embedder url=”https://3dheals.com/wp-content/uploads/2018/08/Getting-to-Innovation-4.0.pdf”]
Time:
Wed, September 5, 2018
6:30 PM – 9:30 PM Singapore Standard Time Singapore Time

Agenda: 

6:30-7:00 PM Networking & Light reception
7:00-7:10 PM Opening Intro by Dr. Jenny Chen and Mahendran Reddy (3DHEALS Singapore Community manager, NAMIC)
7:10 – 7:20 PM Sean Looi is the General Manager of Creatz3D Pte Ltd
7:20-7:25 PM Q&A
7:25-7:35 PM Dr. Chaw Sing Ho, co-founding Managing Director of NAMIC (National Additive Manufacturing Innovation Cluster)
7:35-7:40 PM Q&A
7:40-7:50 PM Dr. Ching Kit Chen, Pediatric Cardiologist, KK Women’s and Children’s Hospital
7:50 -7:55 PM Q&A
7:55-8:05 PM Dr. Shweta Agarwala 
(Singapore Centre for 3D Printing@ Nayang TechnologicalUniversity)
8:05-8:10 PM Q&A
8:10 -8:40 PM Panel Discussion
8:40-9:30 Networking
About Speakers:
Jenny Chen, MD – 3DHEALS

Jenny is trained as a neuroradiologist, founder/CEO of 3DHEALS, a company focusing on curating healthcare 3D printing ecosystem. Her main interests include medical education,  3D printing in the healthcare sector, and artificial intelligence. She is also a current adjunct clinical faculty in the radiology department at Stanford Healthcare.
Mahendran Reddy – 3DHEALS Community Manager, NAMIC

Mahendran Reddy is a highly driven professional with 20 years of international professional experience in the creative industries in both the private and public sectors.
As a trained architect and a media personality, he has held key strategic appointments in driving innovation and initiatives in the civil service, notably the establishment of the National Design Centre in Singapore.
At UCT, he has driven the adoption of Additive Manufacturing in its fledgling form in South East Asia mainly in the consumer segment of the business.
At NAMIC, he is actively involved in the adoption of Additive Manufacturing in the Industries by initiating collaborative research projects with Industry and Institutes of Higher Learning.
He brings with him an in-depth knowledge in management, government processes and procurement, design thinking skills and excellent interpersonal and professional competencies.
Dr. Chaw Sing Ho

Dr. Chaw Sing Ho is the co-founding Managing Director of NAMIC (National Additive Manufacturing Innovation Cluster), a Singapore government initiative to catalyze innovation and scale industrial adoption of additive manufacturing technologies. By focusing on industrial applications and translational R&D, together with commercial strategies to co-create innovative products and services, the national initiative aims to position Singapore as one of the leading digital manufacturing hubs in the era of digitalization and smart factories. Since its inception two years ago, NAMIC has raised more than $24 million in public-private funding to support various AM initiatives across industry verticals.
Prior to NAMIC, he oversaw IP Innovation Strategic Partnerships at HP Singapore. Before that, he was the global head of manufacturing supply chain operations and product innovation for the consumer inkjet supplies business in HP. Chaw Sing started his career in the semiconductor industry with Chartered Semiconductor and Globalfoundries, where he undertook various leadership and customer-facing roles in technology development and engineering operations.
Chaw Sing holds a doctorate in Electrical and Computer Engineering and a Bachelor’s (honors) degree in Electrical Engineering majoring in Microelectronics from the National University of Singapore (NUS). He is an avid inventor with several US/international patents. An advocate for 3D Printing and its role in the new economy, he has spoken in various forums and workshops. He mentors a number of start-ups in the digital and healthcare space. He sits on a number of advisory and expert committees and is an appointed mentor under the GE Digital ASEAN Startup and Partner Program. He is personally interested in nurturing deep tech start-ups, as well as advancing STEM education and engineering as a profession. In his free time, he enjoys sports, movies, reading and spending time with his family.
Dr. Chen Ching Kit

Dr. Ching Kit Chen completed his undergraduate medical studies at the National University of Singapore and post-graduate training in Paediatrics and Paediatric Cardiology in Singapore. He subsequently did a fellowship in pediatric heart failure, mechanical circulatory support and heart transplantation at the Hospital for Sick Children, Toronto, Canada.  During his 2-year fellowship, he participated in a range of research projects resulting in numerous abstracts and publications. Upon returning to Singapore, he has started a pediatric advanced heart failure program (including mechanical circulatory support for children) in KK Women’s and Children’s Hospital and has successfully established a pediatric heart transplant and mechanical cardiac support program in Singapore.  His clinical areas of interest cover dilated cardiomyopathy, exercise echocardiography in cardiomyopathy and congenital heart disease, and fetal cardiovascular flow dynamics, while research areas of expertise and experience include 3D printing of heart models, exercise echocardiography, and fetal cardiology.
Sean Looi

Sean Looi is the General Manager of Creatz3D Pte Ltd, the authorized distributor of Stratasys™ 3D printing systems and materials in Singapore, Vietnam, and Indonesia. Creatz3D’s additive manufacturing solutions also include Arcam™ for production of metal components as well as Materialise™ Rapid Prototyping Softwares. 
Despite majoring in MSc Finance, Sean’s passion for 3D printing opened the door of opportunity of distributing 3D printing technologies in 2007. His knowledge in various manufacturing practices placed him in a favorable position to advice on advanced solutions for direct digital manufacturing.
Sean’s accumulated technical experience with a variety of different 3D printing machines, technologies, and applications, across all industry sectors, helped him to gain foresight into the macroeconomy of additive manufacturing potential.
In return, Sean has been actively helping companies various sectors think more critically, innovate better to improve workflow and is highly respected in the local Additive Manufacturing committee. With over 6 years of experience in the industry, Sean is a regularly invited keynote speaker in various local institutions and events.

Shweta Agarwala is a researcher with Singapore Centre for 3D printing at Nanyang Technological University, Singapore. She holds Ph.D. in Electronics Engineering from National University of Singapore, Singapore. Her research is aimed at developing materials and devices for bioelectronic in healthcare applications, and printed electronics for wearables, sensors and smart packaging. The roadmap employs 3D printing route of an aerosol jet, inkjet, and bio-printing to fabricate nano-electronic and bioelectronic devices. Her research is multidisciplinary in nature and provides a useful link between electronics, material science, manufacturing, and biotechnology, thus trying to solve real-life problems.

Registration

Thanks to our sponsors:

The post 3DHEALS Singapore: Healthcare 3D Printing and Beyond 🗓 🗺 appeared first on 3DHeals.

Applicant company entry qualification: 

• Product or technology needs to focus on healthcare applications using 3D printing or bioprinting/bio-fabrication technologies, 3D Visualization tools (e.g. VR/AR), or a combination of these.
• The startup may be (and not limited to) software, hardware, or material oriented. 
• The startup needs to be an early stage in funding  (pre-seed, seed, or series A).

Prize:

GE Ventures will offer:

• 90 minutes of 1:1 coaching on company’s pitch
• Opportunity to pitch to the GE Ventures Healthcare Additive team
• Post-pitch session with written feedback from GE
• Unique opportunity to interact with GE’s Subject Matter Experts and investors

3DHEALS will offer: 

• Online Pitch3D opportunity (company profile and pitch video will be promoted on the homepage) with the potential of seed funding.
• 60 minute 1:1 strategy consulting with Jenny Chen
• Unique opportunity to interact with 3DHEALS expert networks and investors

Medicus Ventures will offer: 

• 30-minute second meeting pitch directly to the MV team with the potential of seed funding.
• Up to 60 minutes 1:1 coaching on company pitch and strategy from MV team. 

Cash prize pending, stay tuned…

To Enter: 

Please complete the application and send your pitch deck by Noon PST October 15th, 2018 to info@3dheals.com. We will select up to 10 startups to pitch during the In(3D)usury summit on October 17th, 2018, 1-2 PM. 

Investors/judges:

(If you would like to participate as an investor or judge for the pitch competition, please send email to info@3dheals.com)

Judges: 

 

Jenny Chen is a Harvard-trained neuroradiologist, founder/CEO of 3DHEALS, a company focusing on curating healthcare 3D printing ecosystem. She also recently joined Medicus Ventures as a general partner, focusing on investing in early-stage healthcare technology startups, in particular in the space of healthcare 3D printing and bio printing.  Her main interests include medical education, healthcare 3D printing and bio printing, and artificial intelligence. She is also a current adjunct clinical faculty in the radiology department at Stanford Healthcare.

Jessica A. Zeaske, PhD, MBA, serves as Director of Healthcare Investments at GE Ventures in Boston, MA.  At GE Ventures, Jessica focuses on Health IT, IT-enabled Health Services, and Non-Invasive Medical Technology investments.  Jessica came to GE Ventures from Lemhi Ventures, a fund investing exclusively in health care services and HCIT with over $330M under management based in Minneapolis, Minnesota.  At Lemhi, Jessica developed investment hypotheses, sourced deals, ran diligence processes, and served on multiple Boards.  Prior to joining Lemhi, Jessica worked on forming and spinning out companies based on University intellectual property at University of Minnesota and Oregon Health & Science University.  Jessica began her career writing software for a start-up health care delivery company. She then moved to a merchant bank, Greenspring Advisors, where she wrote numerous business plans, evaluated, launched and invested in data-driven health care start-up companies.  Jessica received an undergraduate degree with honors from Stanford University, graduated from Johns Hopkins School of Public Health with a Master of Health Science and PhD, and completed her MBA with a focus on Healthcare Administration at Regis University.  Jessica is currently on the Board of Apervita and Arcadia, and a Board Observer at CareMerge.  She previously served on the Boards of PokitDok, PlanSource, OneHealth, Orasi Medical, and Medication Management Solutions.  Jessica stays involved with Stanford University by volunteering in various capacities, coaches early stage companies in the public health sector, and serves as a start-up judge and panelist for multiple healthcare conferences.

Josep Sanfeliu is the co-founder of Ysios Capital Partners. His career is focused on the structuring of investment deals and, in particular, those concerned with medical technology. He is currently an observer on the Endosense board and a member of MedLumics’, DermaLumics’ and SABIRMEDICAL’s boards”.

Josep’s specialties include financial evaluations, M & A and advising entrepreneurs with regard to IP matters. Josep has gained his experience in some of the most prestigious firms, starting out as an associate at Cuatrecasas in the fields of mergers and acquisitions, venture capital and intellectual property. He then went on to join the consulting firms KPMG or Eurohold Corporate Finance and focused on project innovation, business development, and venture capital.

Over the last 5 years, Josep has been working, from a pharmaceutical and healthcare perspective, in the health sector, starting this stage of his career at Almirall as the Corporate Finance and Business Development Manager. There he worked on investment projects (mergers, acquisitions, and venture capital) and business development projects (licensing, partnerships, joint ventures, etc.), both in Europe and the United States. His most recent position was that of Director General at SARDomus and steering committee member at the SAR group, where he was responsible for more than 300 professionals in the field of healthcare.

Josep holds a degree in Law from the Universitat Pompeu Fabra in Barcelona, a Master’s degree in Law specializing in Intellectual Property and International Transactions from the University of Michigan, Ann Arbor, United States, and an MBA (Global Executive MBA) from IESE (Navarra University).

Maribel Berges is CFO/CBO and Board member of ( Spherium Biomed, S.L.) (Ferrer group), she was the founding partner of the company where she is responsible for investment management and business development. She specializes in the analysis of the value of biomedical projects and negotiation of agreements both in and out-licensing. She started her career in Almirall in R & D Engineering, developing GMP compliant production methods for new APIs in preclinical and clinical development. Later she was Director of Business Center of FBG-University of Barcelona, where she advised more than 50 entrepreneurs in writing and financing their business plans and was responsible for licensing University of Barcelona patents, negotiating several international licensing out agreements. She earned a Chemical Engineering degree from IQS (Universitat Ramon Llull), specialized in Organic Chemistry, and holds an MBA from IESE Business School.

In Spherium, she focusses in defining strategy of new projects, negotiating investment and licensing agreements and business development.

Dr. Liuís Pareras, MD and Ph.D. in Medicine, a specialist in Neurosurgery, and Global Executive MBA (IESE). Director of Healthequity SCR, a VC fund investing in biotechs and medical devices. He founded the innovation and entrepreneurship program at the Barcelona Medical Association, analyzing more than 400 business plans per year, and he has been involved in investments and follow-ons in different healthcare startups. He is a board member in several companies, including Healthequity’s investments Versantis, N-life and Minoryx. Founder and director of the Healthcare Investment Forums (>20 editions celebrated already in Barcelona, with more than 600 companies presented).

He has been an entrepreneur himself in the healthcare sector and raised capital from investors. Deeply involved in the Spanish innovation ecosystem, he is member and advisor of many healthcare innovation organizations such as Biocat (board of trustees), CIMTI.cat, BarcelonaActiva Mentoring Program, Generalitat de Catalunya-CASOST, Healthio, Ready for Growth, etc.

Author of numerous books in the field of innovation, venture capital, and health care, the last one being “Innovation and Entrepreneurship in Healthcare”, published internationally (the US and Europe). In the academic space, he teaches regularly in several business schools about healthcare innovation and venture capital (IESE, ESADE, EADA, UPC, TED speaker,…).

Natalia Moreno (La Caixa DayOne ): 17 years in business banking, it motivates me to know that every Friday I return home, week after week, with more knowledge … I love connecting People, Ideas, Talent, Capital and Building. I believe in the long term and I like the new and different Challenges, especially Innovate and Go for everything that begins with a “NEVER has been done or a can not” leading large teams where everything is possible. I enjoy a lot with my Life, my Work and with the new Technological Challenges and the Changes that we have ahead … to be able to work for a Foundation like Obra Social La Caixa, is my biggest professional reward.

17 años en banca de empresas, me motiva saber que cada viernes vuelvo a casa, semana tras semana, con mayor conocimiento… Me encanta conectar Personas, Ideas, Talento, Capital y Construir. Creo en el largo plazo y me gustan los Retos nuevos y diferentes, sobre todo Innovar e Ir a por todo aquello que empieza por un “NUNCA se ha hecho o un NO se puede” liderando a grandes Equipos en lo que todo es posible. Disfruto mucho con mi Vida, mi Trabajo y con los nuevos Retos Tecnológicos y los Cambios que tenemos por delante… poder trabajar para una Fundación como la Obra Social La Caixa, es mi mayor recompensa profesional.

Ramon Pastor is the Vice-President and General Manager of HP’s 3D Multi Jet Fusion Business. This position includes worldwide responsibility for the Research and Development, Marketing and Operations of HP’s 3D Printing Multi Jet Fusion line of solutions. This business has teams in Barcelona, Spain and Vancouver, US. Ramon is also the HP Barcelona Site Manager. Ramon joined HP in 1992. Since then he has held different positions in Operations, R&D, Marketing and Business Management. Prior to his current position, Ramon was VP & GM of the Large Format Design Business, managing the introduction of the HP PageWide XL printers’ series among other important products and solutions. Previously, he was the worldwide R&D Director for the Large Format Printing business. Ramon was responsible for the development of the first multifunction large format printers connected to the web, which represented a revolution for the technical market. He was also responsible for the complete renewal of the Printing platforms in recent years. Before this position, Ramon was the Strategic Marketing Manager responsible for this business. Ramon holds a Master in Engineering form Universitat Politècnica of Catalunya, a Business Degree by IESE in Barcelona and a Bachelor of Arts, as well as formal training in Product Development and Strategy by INSEAD and MIT.

The post 3DHEALS PITCH3D Barcelona – During IN(3D)ustry 2018 🗓 appeared first on 3DHeals.